UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o | Preliminary Proxy Statement |
o | Confidential, for Use of the Commission Only (as permitted by Rule 14a- 6(e)(2) ) |
o | Definitive Proxy Statement |
þ | Definitive Additional Materials |
o | Soliciting Material Pursuant to §240.14a-12 |
CHINA PHARMA HOLDINGS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ | No fee required. |
o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) | Title of each class of securities to which transaction applies: | |
(2) | Aggregate number of securities to which transaction applies: | |
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |
(4) | Proposed maximum aggregate value of transaction: | |
(5) | Total fee paid: | |
o | Fee paid previously with preliminary materials. |
o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(1) | Amount Previously Paid: | |
(2) | Form, Schedule or Registration Statement No.: | |
(3) | Filing Party: | |
(4) | Date Filed: | |
CHINA PHARMA HOLDINGS, INC. | CONTROL ID: | |
REQUEST ID: |
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
for the Annual Meeting of Stockholders |
|||||
DATE: | December 20, 2019 (local time), December 19, 2019 (eastern time) | ||||
TIME: | 9:00 a.m. local time, 8:00 pm eastern time | ||||
LOCATION: | Conference Room, 2nd Floor, Jiahai Building, No. 17 Jinpan Road, Haikou, Hainan Province, China 570216 | ||||
HOW TO REQUEST PAPER COPIES OF OUR MATERIALS | |||||
PHONE:
Call
toll free
|
FAX:
Send
this card to
|
INTERNET:
https://www.iproxydirect.com/CPHI and follow the on-screen instructions. |
EMAIL:
proxy@iproxydirect.com
|
||
This communication represents a notice to access a more complete set of proxy materials available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The proxy statement is available at: https://www.iproxydirect.com/CPHI | |||||
If you want to receive a paper copy of the proxy materials you must request one. There is no charge to you for requesting a copy. To facilitate timely delivery please make the request, as instructed above, before december 5, 2019. | |||||
you may enter your voting instructions at https://www.iproxydirect.com/CPHI
until 11:59 pm eastern time December 18, 2019 |
|||||
The purposes of this meeting are as follows: | ||
1. To elect three independent director nominees to our board to serve until the next annual meeting and until their successors are elected and qualified; 2. to approve the amendment to our 2010 long-term incentive plan 3. to approve, on a non-binding, advisory basis, the compensation of our named executive officer as disclosed in this proxy statement pursuant to the compensation disclousre rules of the securities and exchange commision; and 4. to transact such other business as may properly come before the annual meeting or any adjournment thereof. |
CHINA PHARMA HOLDINGS, INC. SHAREHOLDER SERVICES 1 Glenwood Avenue Suite 1001 Raleigh NC 27603 |
FIRST-CLASS MAIL US POSTAGE PAID RALEIGH NC PERMIT # 870 |
Time Sensitive shareholder information enclosed
IMPORTANT SHAREHOLDER INFORMATION
your vote is important